; and (3) national surge capacity infrastructure deficiencies in hospitals and medical centers. (e) Termination (1) In general The Commission, and all the authorities of this title, shall terminate 60 days after the date on which the final report is submitted under subsection (b). (2) Administrative activities before termination The Commission may use the 60-day period referred to in paragraph (1) for the purpose of concluding its activities, including providing testimony to committees of Congress concerning its reports and disseminating the final report. III State implementation of findings by Commission 301. State implementation of findings (a) Loss of Federal funding Except as provided in subsection (b), any State that fails to implement the findings of the report described in section 310(d) by January 1, 2025, at the State and local level will lose access to all Federal funds for emergency preparedness. (b) Exemption Notwithstanding subsection (a), the Secretary of Homeland Security may exempt a State from the loss of Federal funds if the Secretary determines that the State is working towards implementing the findings in good faith. The Secretary shall evaluate each such exemption every fiscal year. IV Temporary 100 percent expensing for Qualifying Goods 401. Special allowance for certain property (a) In general For purposes of section 168(k) of the Internal Revenue Code of 1986, in the case of any qualified pharmaceutical and medical device manufacturing property which is placed in service after December 31, 2019, and before January 1, 2026— (1) such property shall be treated as qualified property (within the meaning of such section), (2) the applicable percentage otherwise determined under section 168(k) of such Code with respect to such property shall be 100 percent, and (3) paragraph (8) of such section shall not apply. (b) Qualified pharmaceutical and medical device manufacturing property For purposes of this section, the term qualified pharmaceutical and medical device manufacturing property means any